Watson Pharmaceuticals Inc. (WPI) Thursday released the financial results for the third quarter ended 30 September 2012, reporting net income, on GAAP basis, for the quarter of $76.7 million or $0.60 per share, higher than net income of $68.1 million or $0.54 per share reported for the corresponding quarter last year.
Non-GAAP net income for the third quarter increased 24.2 percent to $172.4 million or $1.35 per share, from $138.7 million or $1.09 per share reported in the same period last year.
On average, 22 analysts polled by Thomson Reuters expected earnings per share of $1.28 for the quarter. Analysts' estimates typically exclude one-time items.
Net revenues for the third quarter were $1.28 billion, higher than revenues of $1.08 billion reported in the earlier year quarter. Analysts estimated revenues of $1.27 billion for the quarter.
For 2012, Watson estimates adjusted earnings between $5.85 and $5.95 per share, on total net revenue of around $5.90 billion. Analysts project full-year earnings of $5.80 per share and revenue of $5.54 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.